Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 3
2014 1
2015 2
2016 1
2018 2
2019 1
2020 3
2021 4
2022 6
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
The role of REV-ERB in NASH.
Griffett K, Hayes ME, Boeckman MP, Burris TP. Griffett K, et al. Acta Pharmacol Sin. 2022 May;43(5):1133-1140. doi: 10.1038/s41401-022-00883-w. Epub 2022 Feb 25. Acta Pharmacol Sin. 2022. PMID: 35217816
The mammalian clock and chronopharmacology.
Griffett K, Burris TP. Griffett K, et al. Bioorg Med Chem Lett. 2013 Apr 1;23(7):1929-34. doi: 10.1016/j.bmcl.2013.02.015. Epub 2013 Feb 13. Bioorg Med Chem Lett. 2013. PMID: 23481644 Free PMC article. Review.
Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists.
Griffett K, Hayes M, Bedia-Diaz G, Appourchaux K, Sanders R, Boeckman MP, Koelblen T, Zhang J, Schulman IG, Elgendy B, Burris TP. Griffett K, et al. ACS Chem Biol. 2022 May 20;17(5):1143-1154. doi: 10.1021/acschembio.2c00057. Epub 2022 Apr 13. ACS Chem Biol. 2022. PMID: 35417135
Emerging Role of Nuclear Receptors for the Treatment of NAFLD and NASH.
Welch RD, Billon C, Losby M, Bedia-Diaz G, Fang Y, Avdagic A, Elgendy B, Burris TP, Griffett K. Welch RD, et al. Among authors: griffett k. Metabolites. 2022 Mar 11;12(3):238. doi: 10.3390/metabo12030238. Metabolites. 2022. PMID: 35323681 Free PMC article. Review.
Nuclear receptors and their selective pharmacologic modulators.
Burris TP, Solt LA, Wang Y, Crumbley C, Banerjee S, Griffett K, Lundasen T, Hughes T, Kojetin DJ. Burris TP, et al. Among authors: griffett k. Pharmacol Rev. 2013 Mar 1;65(2):710-78. doi: 10.1124/pr.112.006833. Print 2013 Apr. Pharmacol Rev. 2013. PMID: 23457206 Review.
A dual MTOR/NAD+ acting gerotherapy.
Li J, Kumar S, Miachin K, Bean NL, Halawi O, Lee S, Park J, Pierre TH, Hor JH, Ng SY, Wallace KJ, Rindtorff N, Miller TM, Niehoff ML, Farr SA, Kletzien RF, Colca J, Tanis SP, Chen Y, Griffett K, McCommis KS, Finck BN, Peterson TR. Li J, et al. Among authors: griffett k. bioRxiv. 2023 Jan 19:2023.01.16.523975. doi: 10.1101/2023.01.16.523975. Preprint. bioRxiv. 2023. PMID: 36711589 Free PMC article.
Fructose Promotes Cytoprotection in Melanoma Tumors and Resistance to Immunotherapy.
Kuehm LM, Khojandi N, Piening A, Klevorn LE, Geraud SC, McLaughlin NR, Griffett K, Burris TP, Pyles KD, Nelson AM, Preuss ML, Bockerstett KA, Donlin MJ, McCommis KS, DiPaolo RJ, Teague RM. Kuehm LM, et al. Among authors: griffett k. Cancer Immunol Res. 2021 Feb;9(2):227-238. doi: 10.1158/2326-6066.CIR-20-0396. Epub 2020 Oct 6. Cancer Immunol Res. 2021. PMID: 33023966 Free PMC article.
21 results